Abhinav Leasing Warrant Issue: ₹6 Crore Approved
Key highlights
- Shareholders approved Abhinav Leasing’s ₹6 crore preferential warrant issue with 99.96% votes in favour at the September 16, 2026 AGM.
- The company plans to issue 6,00,00,000 warrants at ₹1 each, with 25% payable upfront and 75% upon exercise within 18 months.
- Four non-promoter entities will receive 1,50,00,000 warrants each under the proposed issue.
- Authorised share capital will increase from ₹5 crore to ₹12 crore, supporting potential conversion of the warrants into 6,00,00,000 equity shares.
powered by IRIS

Shareholders clear the proposed fundraise
Know Abhinav Leasing & Finance inside out
Results, valuation, peers and who's buying, in one view.
Abhinav Leasing & Finance Limited has received shareholder approval to raise ₹6 crore through a preferential issue of convertible share warrants. The approval was granted at the company's 42nd Annual General Meeting held on September 16, 2026. The company said the proceeds from the issue are earmarked exclusively for working capital requirements. Shareholders approved all five resolutions placed before the meeting. The final voting tally showed 99.96% votes in favour across the agenda items. The warrant issue was approved through a special resolution. The AGM also approved an increase in the company's authorised share capital. These decisions provide the company with the required shareholder mandate for the proposed capital actions.
Terms of the convertible warrant issue
The company plans to issue 6,00,00,000 convertible warrants on a preferential basis. Each warrant has an issue price of ₹1 and carries the right to subscribe to one fully paid-up equity share of face value ₹1. The warrants are being issued at par, with no premium attached to the issue price. The aggregate size of the proposed issue is ₹6 crore. Each warrant can be exercised within 18 months from its allotment date. Warrant holders must pay 25% of the issue price at the time of application. The remaining 75% is payable when the warrants are exercised. The company stated that funds will be used progressively for working capital requirements after conversion or exercise of the warrants.
Four non-promoter entities to receive warrants
The proposed warrants are to be allotted equally among four non-promoter entities. Amrabathi Investra Private Limited is proposed to receive 1,50,00,000 warrants. Masatya Technologies Private Limited is also proposed to receive 1,50,00,000 warrants. Vardan Ceqube India Investment Fund is proposed to receive 1,50,00,000 warrants. Panafic Industrials Limited is proposed to receive the remaining 1,50,00,000 warrants. Together, the four allottees account for the entire issue of 6,00,00,000 warrants. The company has described the proposed placement as a preferential issue to non-promoter entities. Vardan Ceqube India Investment Fund was described in the AGM-related disclosure as a Qualified Institutional Buyer, while the other three proposed allottees were described as non-QIB entities.
Key facts at a glance
Board approval preceded the AGM vote
The company’s board considered the proposed fundraise at its meeting on August 20, 2026. At that meeting, the board approved the preferential issue of convertible warrants, subject to member and applicable regulatory approvals. The board also approved a proposal to increase the authorised share capital. Earlier, the company had indicated that its board would consider a fundraise through convertible share warrants. The August 20 approval established the number of warrants, issue price, conversion terms and proposed allottees. The company subsequently sought shareholder approval through the 42nd AGM. The corporate action timeline identifies August 20, 2026 as the warrant-issue event date. The shareholder vote on September 16 completed the member approval stage cited in the company’s disclosures.
Got a follow-up? Ask IRIS
Authorised share capital raised to ₹12 crore
Alongside the warrant issue, shareholders approved an increase in authorised share capital from ₹5 crore to ₹12 crore. The revised authorised capital is divided into 12,00,00,000 equity shares of ₹1 each. The increase creates additional authorised equity capital for the company. It also aligns the capital structure with the potential conversion of the proposed warrants into equity shares. If exercised, the 6,00,00,000 warrants can result in an equivalent number of equity shares being issued. The authorised capital approval was one of the resolutions considered at the AGM. The company had included this proposal when the board approved the fundraise plan in August. Both the capital increase and warrant proposal were subject to shareholder approval before the AGM vote.
Issue price remains above the revised floor price
The final warrant issue price of ₹1 per warrant remained above the recalculated floor price of ₹0.86, according to the company’s AGM-related update. The company had reopened e-voting after revising the floor price date. The revised floor price did not change the announced issue price of ₹1 per warrant. The issue continues to be at par with the face value of the equity shares. The company also issued a corrigendum to its AGM notice detailing the exclusive use of proceeds for working capital. These disclosures formed part of the information provided to shareholders before the AGM. The resolutions were approved with 99.96% votes in favour. The vote outcome covered the warrant issue and the other matters on the AGM agenda.
Potential equity dilution remains a key consideration
The warrant issue can lead to additional equity shares if warrant holders exercise their conversion rights within the specified 18-month period. Each warrant is convertible into one equity share, making the potential number of new shares equal to 6,00,00,000. The company’s update flagged sharp stake dilution in connection with the proposed issue. A separate disclosure stated that promoter stake would dilute to 1.66% post-issue. The conversion will depend on warrant holders exercising their rights and paying the balance amount due. Until exercise, the instruments remain convertible warrants rather than equity shares. Investors tracking the company’s capital structure will therefore need to consider the conversion terms alongside the enlarged authorised capital. The stated working capital use is the central purpose cited for the fundraise.
Management and compliance developments
Abhinav Leasing & Finance appointed Kamya Sonthalia as Company Secretary from September 8, 2026. The appointment came ahead of the September 16 AGM. The proposed financing transaction was stated to be subject to applicable provisions of the Companies Act, 2013 and SEBI regulations. The company had also indicated that the transaction was subject to board and shareholder approvals. With the AGM resolutions passed, the company has obtained the member approvals referred to in its earlier disclosures. The warrant terms specify the payment schedule and conversion window for the proposed allottees. The company has not stated a separate use of proceeds beyond working capital requirements. Its disclosures link the financing plan directly to that stated requirement.
What the approval means for Abhinav Leasing
The AGM approval allows Abhinav Leasing & Finance to proceed with its proposed ₹6 crore preferential warrant issue, subject to applicable regulatory requirements. The structure gives the four proposed allottees up to 18 months from allotment to exercise their warrants. The company will receive 25% of the issue price on application and the balance at exercise under the disclosed terms. The authorisation to increase share capital to ₹12 crore supports the potential issuance of shares on conversion. Shareholders approved the measures with 99.96% support across the AGM resolutions. The next operational steps relate to allotment and the subsequent exercise of warrants within the prescribed period. The company has stated that the funds are intended exclusively for working capital requirements. Any equity issuance under the warrants will follow the terms approved by shareholders and the applicable regulatory framework.


